'BioConversations'
Biocon's Chairperson Kiran Mazumdar-Shaw in a QnA with FE’s Srinath Srinivasan, talks about the bold moves Biocon Biologics is making since 2021, including the recent acquisition of Viatris’ global biosimilars business, which will provide it a direct entry into the US & Europe with the acquired commercial engine in developed and key emerging markets. This … Continue reading Expect Biocon Biologics to become a fully integrated global biosimilars firm post Viatris buy: Kiran Mazumdar-Shaw
Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League: Kiran Mazumdar-Shaw
India's premier biopharmaceutical company Biocon is working on a pipeline of 20 biosimilar drugs or similar but not identical copy of biologic medicines, to tap the upcoming huge opportunity. Biocon, which launched the world's first interchangeable insulin Glargine in the US during the third quarter, has eight approved products. It has biosimilars in oncology like … Continue reading Biocon developing 20 biosimilar products for global markets
By Dr. Viraj Suvarna Is there a real issue about access to diabetes care? Sir Francis Peabody, renowned physician, says, that the secret in the caring of the patient is in caring for the patient. In other words, despite a plethora of options, Indian patients with diabetes still do not have access to comprehensive diabetes … Continue reading Access to diabetes care; if not now, when?
If you are concerned about your breast health, you might be wondering if there are ways to lower the risk of breast cancer? While one cannot do much about a few risk factors such as being a female or getting older, it is still possible to reduce the risk by adopting some healthy lifestyle habits. … Continue reading HOW CAN I REDUCE MY RISK OF BREAST CANCER?
Dr Arun Chandavarkar, Managing Director, Biocon Biologics Ltd., says the structure of the strategic alliance with Serum Institute Life Sciences provides Biocon Biologics with an asset light and accelerated entry into the often overlooked infectious diseases segment. Having established capabilities and a track record of success in biologics, Biocon Biologics’ foray into vaccines and antibodies for … Continue reading ‘Our Alliance with Serum Institute Provides an Accelerated Entry into Vaccines’
Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India Pvt. Ltd, have entered into a historic alliance to impact global health. This alliance will complement the strengths and resources of two leading Indian players in addressing inequitable access both in … Continue reading A Unique & Synergistic Alliance to Impact Global Health
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age (15–49 years). Worldwide, nearly 116 million women (3.4%) are afflicted with this syndrome and in India, around 10% of women are grappling with this syndrome, however, there is a dearth of proper published data on the same.1 Emerging evidence … Continue reading Women With PCOS Need Extra Attention During COVID-19
Introduction to World Health Day April 7 is marked as World Health Day each year to draw attention to areas of concern related to global healthcare. In 2021, the World Health Day campaign focuses on building a fairer and healthier world collectively. It is in response to the fact that the ongoing COVID-19 pandemic has … Continue reading World Health Day 2021: Building a Fairer, Healthier World
By Seema Ahuja The experiences we have in our formative years shape our behaviour for a lifetime. The unconscious biases that we pick up are also developed due to our experiences either at home or in society. That is why, we need to be careful on how we bring up our children, what conversations we … Continue reading Choose To Challenge & Never Give Up
A Blog by Biocon 